Greater cardiomyocyte density on aligned compared with random carbon nanofibers in polymer composites

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 5533-5539

  Asiri, Abdullah M ^a   Marwani, Hadi M ^a   Khan, Sher Bahadar ^a   Webster, Thomas J ^a,b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b Northeastern University   (United States)

Author keywords

Aligned; Anisotropy; Carbon nanofibers; Cardiomyocytes; Nanotechnology; Poly(Lactic Co Glycolic acid)

Indexed keywords

CARBON; LACTIC ACID; NANOFIBER; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

CELL ADHESION; CELL LINE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; HEART MUSCLE CELL; HUMAN; TISSUE SCAFFOLD; ULTRASTRUCTURE;

CARBON; CELL ADHESION; CELL LINE; CELL PROLIFERATION; HUMANS; LACTIC ACID; MYOCYTES, CARDIAC; NANOFIBERS; POLYGLYCOLIC ACID; TISSUE SCAFFOLDS;

EID: 84914170933     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S71587     Document Type: Article

References (15)

1. Zhang L, Webster TJ. Nanotechnology and nanomaterials: promises for improved tissue regeneration. Nano Today. 2009;4(1):66–80.
2. Khang D, Kim SY, Liu-Synder P, Palmore GTR, Durbin SM, Webster TJ. Enhanced fibronectin adsorption on carbon nanotubes/poly(carbonate) urethane: independent role of surface nano roughness and associated surface energy. Biomaterials. 2007;28(32):4745–4768.
3. Stout DA, Basu B, Webster TJ. Poly(lactic-co-glycolic acid): carbon nanofiber composites for myocardial tissue engineering applications. Acta Biomater. 2011;7(8):3101–3112.
4. Meng X, Stout D, Sun L, Fenniri H, Webster TJ. Injectable biomimetic hydrogels with carbon nanofibers and novel self-assembled chemistries for myocardial applications. In: Narayan N, Bose S, Bandyopadhyay A, editors. Biomaterials Science: Processing, Properties and Applications II: Ceramic Transactions. Volume 237. Hoboken, NJ, USA: John Wiley and Sons, Inc; 2012.
5. Stout DA, Yoo J, Santiago-Miranda AN, Webster TJ. Mechanisms of greater cardiomyocyte functions on conductive nanoengineered composites for cardiovascular applications. Int J Nanomedicine. 2012;7: 5653–5669.
6. Christman KL, Lee RJ. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol. 2006;48(5):907–913.
7. Engelmayr GC, Cheng M, Bettinger CJ, Borenstein JT, Langer R, Freed LE. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater. 2008;7(12):1003–1010.
8. Jalil J, Doering C, Janicki J, Pick R, Shroff S, Weber K. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res. 1989;64(6):1041–1050.
9. Mirsky I, Parmley WW. Assessment of passive elastic stiffness for isolated heart muscle and the intact heart. Circ Res. 1973;33(2):233–243.
10. Boublik J, Park H, Radisic M, et al. Mechanical properties and remodeling of hybrid cardiac constructs made from heart cells, fibrin, and biodegradable, elastomeric knitted fabric. Tissue Eng. 2005;11(7–8): 1122–1132.
11. Phillips CA, Petrofsky JS. Myocardial material mechanics: characteristic variation of the circumferential and longitudinal systolic moduli in left ventricular dysfunction. J Biomech. 1984;17(8):561–568.
12. Willems IE, Arends JW, Daemen MJ. Tenascin and fibronectin expression in healing human myocardial scars. J Pathol. 1996;179(3): 321–325.
13. Landa N, Miller L, Feinberg MS, et al. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation. 2008;117(11):1388–1396.
14. Bajaj P, Khang D, Webster TJ. Control of spatial cell attachment on carbon nanofiber patterns on polycarbonate urethane. Int J Nanomedicine. 2006;1(3):361–366.
15. Price RL, Webster TJ. Increased osteoblast viability in the presence of smaller nano-dimensioned carbon fibers. Nanotechnology. 2004;15(8): 892–900.